Augmented anti-cancer effect of hypoxia-inducible factor 2α (HIF2α)- targeting PT2385 delivered in α-synuclein-AuNP microcapsules for clear cell renal carcinoma mouse model
- Authors
- Nam, Eun-Jeong; Kong, Su-Kang; Cho, Inyoung; Paik, Seung R.; Kim, Young-Sik
- Issue Date
- Jan-2024
- Publisher
- ELSEVIER
- Keywords
- Cancer-targeting drug delivery system; Clear cell renal cell carcinoma xenograft model; Gold nanoparticle-assembled microcapsules; PT2385; Tumor microenvironment
- Citation
- Journal of Drug Delivery Science and Technology, v.91
- Indexed
- SCIE
SCOPUS
- Journal Title
- Journal of Drug Delivery Science and Technology
- Volume
- 91
- URI
- https://scholarworks.korea.ac.kr/kumedicine/handle/2021.sw.kumedicine/65116
- DOI
- 10.1016/j.jddst.2023.105179
- ISSN
- 1773-2247
2588-8943
- Abstract
- Development of anti-cancer drug carrier system capable of delivering chemotherapeutic and immunotherapeutic agents to cancerous lesions is essential to overcome severe side effects and reduced therapeutic efficacy of the drugs. The microcapsules of gold nanoparticles (AuNPs) fabricated with a self-assembly protein of alpha-synuclein (alpha S) have been employed to carry the hypoxia-inducible factor 2 alpha (HIF2 alpha)-targeting PT2385 in a mouse model xenografted with clear cell renal cell carcinoma (ccRCC). Hydrophobic cargo like rhodamine 6G entrapped within the microcapsules was demonstrated to be selectively released under cancer-related stimuli including acidic pH, local hyperthermia, and proteases such as matrix metalloproteinases. The alpha S-AuNP mi-crocapsules containing the hydrophobic drug of PT2385 suppressed the expression of HIF2 alpha and its downstream genes in ccRCC A498 cells in vitro to the level comparable to that obtained with direct PT2385 treatment, indicating that the PT2385 remained active inside the capsules. In the A498 xenograft mouse model, intraper-itoneal administration of the alpha S-AuNP-PT2385 microcapsules significantly reduced the tumor volume and Ki-67 scores from those monitored in the PT2385-treated group. Therefore, the alpha S-AuNP microcapsule is suggested to be a promising cancer-targeting drug delivery system which exhibits several merits such as improved loading efficiency for hydrophobic drugs, their protection from metabolism, and selective cargo release in tumor mi-croenvironments in addition to its physicotherapeutic potential due to the photothermal effect of AuNPs.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 1. Basic Science > Department of Pathology > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.